Skip to main content

Table 2 Detailed clinical history of patients

From: [177Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results

Patient Age/gender Type of cancer Previous therapy Ongoing treatment Analgesic score (type) Analgesic score (quantity)
1 51/M mCRPC First- and second-generation anti-androgens, chemotherapy Androgen synthesis inhibitor Morphine 2
2 25/F Non-small cell right lung cancer Lobectomy, chemotherapy, radiotherapy Morphine 2
3 60/M Right breast cancer Chemotherapy, radiotherapy Morphine 2
4 44/F B/L breast cancer B/L breast mastectomy, chemotherapy, radiotherapy, monoclonal antibody therapy Morphine 2
5 61/M Right breast cancer Hormonal therapy, chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 3
6 70/M mCRPC Medical castration, first-generation anti-androgen therapy, chemotherapy, radiotherapy Second-generation anti-androgens Morphine 4
7 63/M mCRPC B/L orchidectomy, first-generation anti-androgens, chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 2
8 60/F Small-cell lung cancer Chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 3
9 44/F Right breast cancer Right breast mastectomy, hormonal therapy, chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 2
10 65/F Left breast cancer Hormonal therapy, chemotherapy, Atypical opioids and non-morphine opioids 2
11 33/F Right breast cancer Chemotherapy, radiotherapy Morphine 2
12 74/M mCRPC Radical Prostatectomy, B/L orchidectomy, first-generation anti-androgens, chemotherapy, - Atypical opioids and non-morphine opioids 2
13 45/F Left breast cancer Left breast modified radical mastectomy, hormonal therapy, chemotherapy, radiotherapy, Atypical opioids and non-morphine opioids 3
14 27/F B/L breast cancer Hormonal therapy, B/L mastectomy, chemotherapy, radiotherapy, Morphine 2
15 47/F Left breast cancer Hormonal therapy, chemotherapy, radiotherapy, antibody therapy Other NSAIDs 1
16 27/F Left breast cancer chemotherapy, radiotherapy, Other NSAIDs 2
17 55/M mCRPC B/L orchidectomy, first- and second-generation anti-androgens, chemotherapy, radiotherapy Androgen synthesis inhibitors Other NSAIDs 3
18 44/F Left breast cancer Left modified radical mastectomy, chemotherapy, radiotherapy Morphine 2
19 58/F Right breast cancer Rt breast mastectomy chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 4
20 24/M Squamous cell cancer of lung Surgery, chemotherapy Morphine 2
21 55/F Left breast cancer Surgery, chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 2
22 55/F Squamous cell cancer of lung Chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 2
23 54/F Right breast cancer Chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 3
24 40/F Right breast cancer Chemotherapy, radiotherapy Morphine 2
25 54/M mCRPC Medical castration, Chemotherapy, radiotherapy Androgen-synthesis inhibitors Morphine 2
26 63/F B/L breast cancer Bilateral mastectomy, chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 2
27 47/F Right breast cancer Right breast mastectomy, hormonal therapy, chemotherapy, radiotherapy Morphine 2
28 50/M Right breast cancer Right modified radical mastectomy, chemotherapy, radiotherapy Morphine 2
29 40/F B/L breast cancer Hormonal therapy, chemotherapy, radiotherapy Morphine 2
30 75/M mCRPC B/L orchidectomy, chemotherapy, first- and second-generation anti-androgens, radiotherapy None Atypical opioids and non-morphine opioids 2
31 67/M mCRPC B/L orchidectomy, first-generation anti-androgens
Chemotherapy, radiotherapy,
Second-generation anti-androgens Atypical opioids and non-morphine opioids 2
32 78/M mCRPC B/L orchidectomy, chemotherapy Androgen synthesis inhibitor Atypical opioids and non-morphine opioids 2
33 48/F B/L breast cancer Chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 2
34 40 Right breast cancer Right modified radical mastectomy, chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 2
35 70/M mCRPC Medical castration, chemotherapy, radiotherapy Androgen-synthesis inhibitors Morphine 2
36 43/M Non-small cell lung cancer of the right lung Chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 2
37 32/F Right breast cancer Right breast mastectomy chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 2
38 67/F Right breast cancer Right modified radical mastectomy, hormonal therapy chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 2
39 30/F Small cell cancer of lung Chemotherapy, radiotherapy Atypical opioids and non-morphine opioids 3
40 76/M mCRPC B/L orchidectomy, first-generation anti-androgens, chemotherapy, radiotherapy Second-generation anti-androgens Atypical opioids and non-morphine opioids 2
  1. B/L bilateral, mCRPC metastatic castration-resistant prostate cancer